600998 九州通
已收盘 02-06 15:00:00
资讯
新帖
简况
九州通(600998)股东上海弘康实业投资有限公司质押1600万股,占总股本0.32%
证券之星 · 02-05 18:31
九州通(600998)股东上海弘康实业投资有限公司质押1600万股,占总股本0.32%
九州通涨5.08%,中邮证券二个月前给出“买入”评级
证券之星 · 01-23
九州通涨5.08%,中邮证券二个月前给出“买入”评级
异动快报:九州通(600998)1月23日9点34分触及涨停板
证券之星 · 01-23
异动快报:九州通(600998)1月23日9点34分触及涨停板
九州通(600998)披露完成工商变更登记及章程备案,1月22日股价上涨1.14%
证券之星 · 01-22
九州通(600998)披露完成工商变更登记及章程备案,1月22日股价上涨1.14%
九州通医药集团成功发行3亿元科技创新债券,票面利率1.7%
中金财经 · 01-22
九州通医药集团成功发行3亿元科技创新债券,票面利率1.7%
九州通(600998)股东中山广银投资有限公司质押6460万股,占总股本1.28%
证券之星 · 01-21
九州通(600998)股东中山广银投资有限公司质押6460万股,占总股本1.28%
九州通(600998)披露为子公司提供担保的进展公告,1月16日股价下跌2.78%
证券之星 · 01-16
九州通(600998)披露为子公司提供担保的进展公告,1月16日股价下跌2.78%
每周股票复盘:九州通(600998)盐酸布比卡因注射液获注册证
证券之星 · 01-11
每周股票复盘:九州通(600998)盐酸布比卡因注射液获注册证
九州通(600998)发布2026年度授信及担保计划,1月7日股价下跌2.06%
证券之星 · 01-07
九州通(600998)发布2026年度授信及担保计划,1月7日股价下跌2.06%
九州通(600998.SH):盐酸布比卡因注射液获得药品注册证书
智通财经 · 01-06
九州通(600998.SH):盐酸布比卡因注射液获得药品注册证书
凯乐士冲刺港股:9个月营收5.5亿 经营亏损3501万 顺丰九州通是股东
雷递网 · 01-06
凯乐士冲刺港股:9个月营收5.5亿 经营亏损3501万 顺丰九州通是股东
九州通(600998)发布召开2026年第一次临时股东会的提示性公告,1月5日股价上涨3.91%
证券之星 · 01-05
九州通(600998)发布召开2026年第一次临时股东会的提示性公告,1月5日股价上涨3.91%
每周股票复盘:九州通(600998)奥园美谷重整计划执行完毕
证券之星 · 01-02
每周股票复盘:九州通(600998)奥园美谷重整计划执行完毕
九州通(600998)股东上海弘康实业投资有限公司质押1.22亿股,占总股本2.42%
证券之星 · 2025-12-30
九州通(600998)股东上海弘康实业投资有限公司质押1.22亿股,占总股本2.42%
九州通全资子公司参与重整的奥园美谷重整计划执行完毕
中金财经 · 2025-12-30
九州通全资子公司参与重整的奥园美谷重整计划执行完毕
每周股票复盘:九州通(600998)控股股东完成债券兑付持股升至9.11%
证券之星 · 2025-12-28
每周股票复盘:九州通(600998)控股股东完成债券兑付持股升至9.11%
九州通(600998.SH):盐酸异丙嗪注射液获得药品注册证书
智通财经 · 2025-12-26
九州通(600998.SH):盐酸异丙嗪注射液获得药品注册证书
九州通(600998)披露控股股东完成可交换债兑付并拟办理解除股票担保登记,12月23日股价下跌0.2%
证券之星 · 2025-12-23
九州通(600998)披露控股股东完成可交换债兑付并拟办理解除股票担保登记,12月23日股价下跌0.2%
九州通(600998)披露召开2026年第一次临时股东会通知,12月19日股价下跌0.38%
证券之星 · 2025-12-19
九州通(600998)披露召开2026年第一次临时股东会通知,12月19日股价下跌0.38%
九州通医药集团股份有限公司获准注册60亿元债务融资工具
中金财经 · 2025-12-19
九州通医药集团股份有限公司获准注册60亿元债务融资工具
加载更多
公司概况
公司名称:
九州通医药集团股份有限公司
所属行业:
批发业
上市日期:
2010-11-02
主营业务:
九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流与供应链解决方案。公司是国内最大的民营医药商业企业,也是行业内首家获评5A级物流企业及唯一获评全国十大“国家智能化仓储物流示范基地”的企业,位列2024年《财富》“中国企业500强”第165位、“中国民营企业500强”第55位。
发行价格:
13.00
{"stockData":{"symbol":"600998","market":"SH","secType":"STK","nameCN":"九州通","latestPrice":5.22,"timestamp":1770361200000,"preClose":5.27,"halted":0,"volume":39456400,"delay":0,"changeRate":-0.0095,"floatShares":5042000000,"shares":5042000000,"eps":0.5527,"marketStatus":"已收盘","change":-0.05,"latestTime":"02-06 15:00:00","open":5.28,"high":5.32,"low":5.21,"amount":208000000,"amplitude":0.0209,"askPrice":5.23,"askSize":2982,"bidPrice":5.22,"bidSize":3190,"shortable":0,"etf":0,"ttmEps":0.5527,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":5.27,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":5.8,"lowLimit":4.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":5042470234,"isCdr":false,"pbRate":0.99,"roa":"--","peRate":9.444545,"roe":"7.3%","epsLYR":0.5,"committee":0.024975,"marketValue":26322000000,"turnoverRate":0.0078,"status":1,"floatMarketCap":26322000000},"requestUrl":"/m/hq/s/600998","defaultTab":"news","newsList":[{"id":"2609140375","title":"九州通(600998)股东上海弘康实业投资有限公司质押1600万股,占总股本0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609140375","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609140375?lang=zh_cn&edition=full","pubTime":"2026-02-05 18:31","pubTimestamp":1770287466,"startTime":"0","endTime":"0","summary":"证券之星消息,九州通2月5日公开信息显示,股东上海弘康实业投资有限公司向汉口银行股份有限公司汉阳支行合计质押1600.0万股,占总股本0.32%。九州通主营业务:涵盖医药流通、医药新零售、医药工业、医药CSO等业态,包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流技术与供应链解决方案六大方面。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500032104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0012","BK0097","BK0188","BK0201","BK0028","BK0250","BK0077","BK0196","BK0039","BK0183","600998","BK0187"],"gpt_icon":0},{"id":"2605424277","title":"九州通涨5.08%,中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2605424277","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605424277?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:33","pubTimestamp":1769153595,"startTime":"0","endTime":"0","summary":"今日九州通涨5.08%,收盘报5.58元。2025年10月29日,中邮证券研究员盛丽华,龙永茂发布了对九州通的研报《Q3经营业绩超预期,现金流持续改善》,该研报对九州通给出“买入”评级。研报中预计公司2025-2027年营业收入分别为1640.51/1773.30/1916.34亿元,归母净利润分别为25.09/27.60/30.46亿元,当前股价对应PE分别为10.0/9.1/8.2倍,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为开源证券的余汝意。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300019670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600998"],"gpt_icon":0},{"id":"2605444156","title":"异动快报:九州通(600998)1月23日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2605444156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605444156?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:37","pubTimestamp":1769132220,"startTime":"0","endTime":"0","summary":"证券之星1月23日盘中消息,9点34分九州通触及涨停板。其所属行业医药商业目前上涨。领涨股为华人健康。该股为医药商业,医疗耗材供应链SPD,互联网医疗概念热股,当日医药商业概念上涨2.23%,医疗耗材供应链SPD概念上涨1.36%,互联网医疗概念上涨1.0%。1月22日的资金流向数据方面,主力资金净流入236.01万元,占总成交额1.15%,游资资金净流出725.08万元,占总成交额3.53%,散户资金净流入489.07万元,占总成交额2.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300008650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0201","BK0097","BK0250","BK0196","600998","BK0012","BK0077","BK0028","BK0187","BK0188","BK0146","BK0183"],"gpt_icon":0},{"id":"2605497723","title":"九州通(600998)披露完成工商变更登记及章程备案,1月22日股价上涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605497723","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605497723?lang=zh_cn&edition=full","pubTime":"2026-01-22 22:40","pubTimestamp":1769092827,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘,九州通报收于5.31元,较前一交易日上涨1.14%,最新总市值为267.76亿元。该股当日开盘5.25元,最高5.32元,最低5.23元,成交额达2.06亿元,换手率为0.77%。公司近日发布公告称,九州通医药集团股份有限公司于2026年1月7日召开2026年第一次临时股东会,审议通过增加经营范围及修订《公司章程》的议案。公司已于2026年1月21日完成工商变更登记及章程备案,并取得湖北省市场监督管理局换发的《营业执照》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200041180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0201","BK0097","BK0250","BK0196","600998","BK0012","BK0077","BK0028","BK0187","BK0188","BK0146","BK0183"],"gpt_icon":0},{"id":"2605043475","title":"九州通医药集团成功发行3亿元科技创新债券,票面利率1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605043475","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605043475?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:10","pubTimestamp":1769040625,"startTime":"0","endTime":"0","summary":"中访网数据 九州通医药集团股份有限公司于2026年1月20日成功发行了2026年度第一期科技创新债券。本期债券简称“26九州通SCP001(科创债)”,实际发行总额为人民币3亿元,期限180天,票面利率为1.7%,募集资金已于1月21日全额到账。此次发行是公司在注册有效期内首次动用该额度,发行完成后,公司累计发行的超短期融资券余额为3亿元。该举措有助于公司优化债务结构,补充运营资金,支持科技创新相关业务发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260122/31961810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0012","BK4585","BK0146","BK0201","BK0188","BK0039","BK4581","BK0187","BK4588","BK0196","BK0183","BK0077","600998","BK0097","BK0250"],"gpt_icon":0},{"id":"2605225103","title":"九州通(600998)股东中山广银投资有限公司质押6460万股,占总股本1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605225103","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605225103?lang=zh_cn&edition=full","pubTime":"2026-01-21 18:33","pubTimestamp":1768991609,"startTime":"0","endTime":"0","summary":"证券之星消息,九州通1月21日公开信息显示,股东中山广银投资有限公司向汉口银行股份有限公司汉阳支行合计质押6460.0万股,占总股本1.28%。九州通主营业务:涵盖医药流通、医药新零售、医药工业、医药CSO等业态,包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流技术与供应链解决方案六大方面。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100032497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0250","BK0188","BK0012","BK0187","BK0097","BK0196","BK0146","600998","BK0028","BK0201","BK0183","BK0039"],"gpt_icon":0},{"id":"2603947099","title":"九州通(600998)披露为子公司提供担保的进展公告,1月16日股价下跌2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603947099","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603947099?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:52","pubTimestamp":1768575134,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,九州通报收于5.25元,较前一交易日下跌2.78%,最新总市值为264.73亿元。近日,九州通医药集团股份有限公司发布关于为子公司提供担保的进展公告。公告显示,公司为54家子公司提供合计488,113.00万元的担保,其中为资产负债率超过70%的子公司担保323,613.00万元。截至2025年12月31日,公司对外担保总额为2,913,612.62万元,占最近一期经审计净资产的106.95%,无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600041617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0039","BK0183","BK0187","BK0201","600998","BK0077","BK0012","BK0188","BK0196","BK0097","BK0028","BK0146"],"gpt_icon":0},{"id":"2602438536","title":"每周股票复盘:九州通(600998)盐酸布比卡因注射液获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2602438536","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602438536?lang=zh_cn&edition=full","pubTime":"2026-01-11 04:05","pubTimestamp":1768075511,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,九州通报收于5.29元,较上周的5.12元上涨3.32%。本周,九州通1月6日盘中最高价报5.48元。本周关注点公司公告汇总:子公司汇禹远和(海南)药业盐酸布比卡因注射液获药品注册证书。2026年1月5日,九州通子公司京丰制药的下属公司汇禹远和(海南)药业有限公司收到国家药监局签发的盐酸布比卡因注射液《药品注册证书》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100001336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0250","BK0012","BK0039","BK0146","BK0097","BK0196","BK0201","BK0183","BK0187","600998","BK0188","BK0028"],"gpt_icon":0},{"id":"2601801334","title":"九州通(600998)发布2026年度授信及担保计划,1月7日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801334?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:24","pubTimestamp":1767795863,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘,九州通报收于5.24元,较前一交易日下跌2.06%,最新总市值为264.23亿元。近日,九州通医药集团股份有限公司披露2026年第一次临时股东会决议公告,会议审议通过了关于2026年度公司及下属企业申请银行等机构综合授信计划、提供担保、委托理财预计、关联交易预计、增加经营范围暨修订《公司章程》、修订《董事、高级管理人员薪酬管理制度》等六项议案。关联股东对关联交易预计议案回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0146","BK0201","BK0039","BK0097","BK0012","BK0196","BK0250","BK0188","BK0183","BK0077","BK0187","600998"],"gpt_icon":0},{"id":"2601675118","title":"九州通(600998.SH):盐酸布比卡因注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2601675118","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601675118?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:23","pubTimestamp":1767687821,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九州通(600998.SH)发布公告,2026年1月5日,公司子公司北京京丰制药集团有限公司(简称“京丰制药”)的下属公司汇禹远和(海南)药业有限公司(简称“汇禹远和”)收到国家药品监督管理局核准签发的盐酸布比卡因注射液《药品注册证书》。盐酸布比卡因注射液是一款酰胺类长效局部麻醉药,主要用于局部浸润麻醉、外周神经阻滞和椎管内阻滞。该药品为国家医保甲类、国家基本药物目录品种。米内网数据显示,2024年盐酸布比卡因注射液在中国三大终端六大市场的销售额超过人民币2亿元。截至本公告日,汇禹远和针对该药品已投入的研发费用约人民币466万元(未经审计)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九州通(600998.SH):盐酸布比卡因注射液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","600998","BK0146","BK0028","BK0183","BK0077","BK0187","BK0196","BK0039","BK0097","BK0201","BK0012","BK0250"],"gpt_icon":0},{"id":"2601690838","title":"凯乐士冲刺港股:9个月营收5.5亿 经营亏损3501万 顺丰九州通是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2601690838","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601690838?lang=zh_cn&edition=full","pubTime":"2026-01-06 14:53","pubTimestamp":1767682423,"startTime":"0","endTime":"0","summary":"浙江凯乐士科技集团股份有限公司(简称:“凯乐士”)日前更新招股书,准备在港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260106/6390330800878311032302780.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260106/6390330800878311032302780.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32296/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["600998","002352"],"gpt_icon":0},{"id":"2601007327","title":"九州通(600998)发布召开2026年第一次临时股东会的提示性公告,1月5日股价上涨3.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601007327","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601007327?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:48","pubTimestamp":1767606507,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,九州通报收于5.32元,较前一交易日上涨3.91%,最新总市值为268.26亿元。该股当日开盘5.13元,最高5.38元,最低5.13元,成交额达4.77亿元,换手率为1.79%。近日,九州通医药集团股份有限公司发布关于召开2026年第一次临时股东会的提示性公告。公告称,公司将于2026年1月7日召开2026年第一次临时股东会,会议采取现场与网络投票相结合方式,网络投票通过上海证券交易所系统进行。股权登记日为2025年12月31日,登记时间截至2026年1月6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500026332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0097","BK0183","BK0201","BK0146","BK0188","BK0196","BK0012","BK0187","BK0028","BK0039","BK0250","600998"],"gpt_icon":0},{"id":"2600036721","title":"每周股票复盘:九州通(600998)奥园美谷重整计划执行完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2600036721","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600036721?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:36","pubTimestamp":1767296173,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,九州通报收于5.13元,较上周的5.18元下跌0.97%。本周关注点公司公告汇总:奥园美谷重整计划执行完毕,法院裁定终结重整程序。公司公告汇总九州通全资子公司九州产投公司出资70620.71万元参与奥园美谷科技股份有限公司重整,受让转增股票43593.0312万股。上海弘康于2025年12月29日提前解除质押125,600,000股,占其所持股份的11.54%,占公司总股本的2.49%。股本股东变化上海弘康本次变动后累计质押股份650,924,549股,占其所持股份的59.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0250","600998","BK0097","BK0183","BK0028","BK0196","BK0077","BK0188","BK0039","BK0146","BK0187","BK0012"],"gpt_icon":0},{"id":"2595779932","title":"九州通(600998)股东上海弘康实业投资有限公司质押1.22亿股,占总股本2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595779932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595779932?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:41","pubTimestamp":1767091295,"startTime":"0","endTime":"0","summary":"证券之星消息,九州通12月30日公开信息显示,股东上海弘康实业投资有限公司向中国民生银行股份有限公司武汉分行合计质押1.22亿股,占总股本2.42%。九州通主营业务:涵盖医药流通、医药新零售、医药工业、医药CSO等业态,包括数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流技术与供应链解决方案六大方面。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000032678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0196","BK0097","BK0028","BK0250","BK0039","BK0201","BK0077","600998","BK0187","BK0183","BK0188","BK0012"],"gpt_icon":0},{"id":"2595576997","title":"九州通全资子公司参与重整的奥园美谷重整计划执行完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2595576997","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595576997?lang=zh_cn&edition=full","pubTime":"2025-12-30 09:56","pubTimestamp":1767059783,"startTime":"0","endTime":"0","summary":"中访网数据 九州通医药集团股份有限公司于2025年12月30日发布公告,其全资子公司湖北九州产业园区运营管理有限公司参与重整投资的奥园美谷科技股份有限公司重整计划已执行完毕。湖北省襄阳市中级人民法院于2025年12月29日裁定终结奥园美谷重整程序。九州通表示,此举符合其长期战略规划,旨在通过整合自身医药供应链体系与运营管理经验,赋能奥园美谷的美丽健康业务,拓展产业链。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251230/31902499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0039","600998","BK0183","BK0097","BK0012","BK0201","BK0196","BK0250","BK0077","BK0028","BK0187","BK0146"],"gpt_icon":0},{"id":"2594244079","title":"每周股票复盘:九州通(600998)控股股东完成债券兑付持股升至9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594244079","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594244079?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:25","pubTimestamp":1766863512,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,九州通报收于5.13元,较上周的5.18元下跌0.97%。本周,九州通12月22日盘中最高价报5.18元。本周关注点公司公告汇总:控股股东完成可交换债兑付,持股比例由7.54%增至9.11%。本次划转后,楚昌投资合计持有公司股份459,506,100股,持股比例由7.54%增至9.11%。九州通关于盐酸异丙嗪注射液获得药品注册证书的公告2025年12月25日,九州通子公司京丰制药下属公司汇禹远和收到国家药监局核准签发的盐酸异丙嗪注射液药品注册证书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0183","BK0097","BK0012","BK0201","BK0077","BK0196","BK0146","BK0250","BK0028","BK0188","600998","BK0039"],"gpt_icon":0},{"id":"2594226223","title":"九州通(600998.SH):盐酸异丙嗪注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2594226223","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594226223?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:16","pubTimestamp":1766736995,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九州通(600998.SH)发布公告,2025年12月25日,公司子公司北京京丰制药集团有限公司(简称“京丰制药”)的下属公司汇禹远和(海南)药业有限公司(简称“汇禹远和”)收到国家药品监督管理局核准签发的盐酸异丙嗪注射液《药品注册证书》。盐酸异丙嗪注射液为抗组胺药,适用于皮肤粘膜过敏、晕动病、麻醉和手术前后的辅助治疗、防治放射病性或药源性恶心、呕吐。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九州通(600998.SH):盐酸异丙嗪注射液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0146","BK0201","BK0039","BK0097","BK0012","BK0196","BK0250","BK0188","BK0183","BK0077","BK0187","600998"],"gpt_icon":0},{"id":"2593416937","title":"九州通(600998)披露控股股东完成可交换债兑付并拟办理解除股票担保登记,12月23日股价下跌0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593416937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593416937?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:47","pubTimestamp":1766501227,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘,九州通报收于5.11元,较前一交易日下跌0.2%,最新总市值为257.67亿元。近日,九州通发布公告称,公司控股股东楚昌投资已完成2022年非公开发行可交换公司债券(第三期)的兑付并摘牌,拟办理解除股票担保及信托登记手续。本次划转后,楚昌投资合计持有公司股份459,506,100股,持股比例由7.54%增至9.11%。公告明确指出,公司控股股东及实际控制人未发生变化,不构成要约收购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300041163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0250","BK0012","BK0039","BK0146","BK0097","BK0196","BK0201","BK0183","BK0187","600998","BK0188","BK0028"],"gpt_icon":0},{"id":"2592018160","title":"九州通(600998)披露召开2026年第一次临时股东会通知,12月19日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592018160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592018160?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:18","pubTimestamp":1766153922,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘,九州通报收于5.18元,较前一交易日下跌0.38%,最新总市值为261.2亿元。该股当日开盘5.2元,最高5.2元,最低5.12元,成交额达2亿元,换手率为0.77%。近日,九州通发布关于召开2026年第一次临时股东会的通知。公告显示,九州通医药集团股份有限公司将于2026年1月7日召开2026年第一次临时股东会,会议采取现场与网络投票相结合方式,网络投票通过上海证券交易所系统进行。股权登记日为2025年12月31日,登记时间截至2026年1月6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0012","600998","BK0146","BK0077","BK0097","BK0250","BK0188","BK0183","BK0187","BK0201","BK0039"],"gpt_icon":0},{"id":"2592138956","title":"九州通医药集团股份有限公司获准注册60亿元债务融资工具","url":"https://stock-news.laohu8.com/highlight/detail?id=2592138956","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592138956?lang=zh_cn&edition=full","pubTime":"2025-12-19 08:09","pubTimestamp":1766102998,"startTime":"0","endTime":"0","summary":"中访网数据 九州通医药集团股份有限公司近日收到中国银行间市场交易商协会下发的《接受注册通知书》,公司超短期融资券和中期票据的注册申请获得通过。根据通知书,公司超短期融资券注册金额为30亿元,由招商银行、中国光大银行等五家机构联席主承销;中期票据注册金额同样为30亿元,由中信银行、中国光大银行等六家机构联席主承销。两项注册额度自通知书落款之日起2年内有效,公司在注册有效期内可分期发行。此次债务融资工具的注册发行事宜已经公司2024年第一次临时股东大会审议批准。公司表示将根据相关规则办理后续发行工作,并及时履行信息披露义务。此举有助于公司优化债务结构,拓宽融资渠道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251219/31875929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0201","BK0250","600998","BK1574","BK0097","BK0183","BK1515","BK0028","BK0196","BK0077","BK0188","159938","BK0039","BK1161","BK0146","BK0187","BK0012","09939"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770382259188,"stockEarnings":[{"period":"1week","weight":-0.0295},{"period":"1month","weight":-0.015},{"period":"3month","weight":0.0293},{"period":"6month","weight":-0.015},{"period":"1year","weight":0.0925},{"period":"ytd","weight":0.0293}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":-0.0019},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.2621},{"period":"ytd","weight":0.027}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"九州通医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"56953人(较上一季度增加36.47%)","perCapita":"88537股","listingDate":"2010-11-02","address":"湖北省武汉市汉阳区龙兴西街5号","registeredCapital":"504247万元","survey":" 九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销与供应链业务、总代品牌推广业务、医药工业自产及OEM业务、新零售与万店加盟业务(C端)、医疗健康(C端)与技术增值服务、数字物流与供应链解决方案。公司是国内最大的民营医药商业企业,也是行业内首家获评5A级物流企业及唯一获评全国十大“国家智能化仓储物流示范基地”的企业,位列2024年《财富》“中国企业500强”第165位、“中国民营企业500强”第55位。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九州通,600998,九州通股票,九州通股票老虎,九州通股票老虎国际,九州通行情,九州通股票行情,九州通股价,九州通股市,九州通股票价格,九州通股票交易,九州通股票购买,九州通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}